A new procedure that delivers and places or repairs a heart valve through a catheter could soon become an alternative to open heart surgery for extremely high-risk patients.
FDA has accepted ARIXTRA (fondaparinux sodium) Injection for priority review — the anticoagulant supplemental drug ...
The genesis of the Abaxis Piccolo technology began with NASA, where scientists sought to develop and manufacture a small ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
SmartPumps are tourniquet systems offering OR connectivity, superior performance, exceptional battery life and intuitive ...
A new study in Denmark links healthy teeth and gums with heart health. Theheart.org reports that Danish investigators ...
Catheters of all types as well as other intravascular devices (IVDs) that allow access to the bloodstream are potential ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Public confidence in the FDA is low and big changes may be in order to fix the system for approving and regulating drugs ...
A retrospective study at Northwestern University Feinberg School of Medicine, Chicago, showed that dialysis patients who ...
Americans Andrew Z. Fire and Craig C. Mello have won the Nobel Prize in medicine Monday for their discover of “RNA ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
FDA and Duke Clinical Research Institute will be working to develop a new generation of tools that enable early identification of potential cardiac side effects of drugs and devices. The agency will use a database comprising more than 200,000 ECGs to conduct the research.
A new, private research group, the Center for Medical Technology Policy is being formed to provide healthcare clinicians ...
Researchers at the Technion Institute, Israel, are developing a new method that may prevent heart attacks following ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
ATS Medical, Inc., a manufacturer of cardiac surgery products and services focused, has announced completion of its ...
Expanding their existing strategic collaboration for atherosclerotic plaque analysis, FoxHollow Technologies and Merck & ...
Administering a cholesterol-lowering drug prior to heart bypass surgery or surgical repair of a faulty heart valve may reduce the occurrence of atrial fibrillation, a common heart rhythm disturbance triggered by these surgeries. The research was published in “Circulation: Journal of the American Heart Association.”